BioLineRx

IPO

BioLineRx is a biotech company in Tel Aviv, Israel, founded in 2003. It has raised $9.0M across 2 rounds, most recently a Series A in September 2005.

Driving innovative therapeutics across the finish line.

Headquarters
Tel Aviv
Employees
51–200
Founded
2003
Business Model
B2B
Total Funding
$9.0M
Last Round
Series ASep 2005
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.

About

BioLineRx (NASDAQ/TASE: BLRX) is a clinical-stage biopharmaceutical company headquartered in Tel Aviv, Israel, focused on developing life-changing therapies for oncology and rare diseases. Founded in 2003 by leaders in the Israeli life sciences industry — including Teva Pharmaceuticals, Giza, Pitango, and Hadasit — the company leverages full-spectrum drug development expertise to advance novel therapeutics from bench through clinical trials to regulatory approval. Its lead programs target glioblastoma (GLIX1) and hematologic malignancies via its approved motixafortide asset.

Summary

It lists 51–200 employees. It has raised $9.0M in total across 2 rounds, most recently a Series A round in Sep 2005. Investors include Giza Venture Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
IPOFeb 2007
$50.0M

Sign up to see all 3 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BioLineRx on Indexed.vc
<a href="https://indexed.vc/companies/biolinerx"><img src="https://indexed.vc/api/badge/company/biolinerx" alt="BioLineRx on Indexed.vc" width="260" height="76" /></a>